Efficacy and safety of anti-TNF therapy for inflammatory bowel disease (IBD) in liver transplant recipients for primary sclerosing cholangitis (PSC): a multicenter experience.

被引:0
|
作者
Combes, R. [1 ]
Altwegg, R. [1 ]
Laharie, D. [2 ]
De Ledinghen, V. [2 ]
Radenne, S. [3 ]
Conti, F. [4 ]
Chazouilleres, O. [4 ]
Duvoux, C. [5 ]
Peyrin-Biroulet, L. [6 ]
Dumortier, J. [7 ]
Leroy, V. [8 ]
Treton, X. [9 ]
Durand, F. [9 ]
Dharancy, S. [10 ]
Nachury, M. [10 ]
Goutorbe, F. [11 ]
Lamblin, G. [11 ]
Pageaux, G. -P. [1 ]
机构
[1] Univ Hosp St Eloi, Dept Hepatol & Gastroenterol, Montpellier, France
[2] Univ Hosp Bordeaux, Haut Leveque Hosp, Hepatogastroenterol, Bordeaux, France
[3] Hosp Civils Lyon, Croix Rousse, Hepatogastroenterol, Lyon, France
[4] Univ Hosp St Antoine, APHP, Hepatogastroenterol, Paris, France
[5] Univ Hosp Henri Mondor, APHP, Hepatogastroenterol, Creteil, France
[6] Univ Hosp Nancy, Gastroenterol, Nancy, France
[7] Hosp Civils Lyon, Edouard Heriot Hosp, Hepatogastroenterol, Lyon, France
[8] Univ Hosp Grenoble, Hepatogastroenterol, Grenoble, France
[9] Univ Hosp Beaujon, APHP, Gastroenterol, Clichy, France
[10] Univ Hosp Lille, Hepatogastroenterol, Lille, France
[11] Univ Hosp Clermont Ferrand, Hepatogastroenterol, Clermont Ferrand, France
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
DOP033
引用
收藏
页码:S40 / S40
页数:1
相关论文
共 50 条
  • [41] Risk of Inflammatory Bowel Disease (IBD)-Associated Colorectal Neoplasia in IBD-Primary Sclerosing Cholangitis (PSC) Appears Greater in Patients Diagnosed With IBD Before PSC
    Dunseth, Craig
    Bellizzi, Andrew
    LABORATORY INVESTIGATION, 2015, 95 : 158A - 158A
  • [42] Risk of Inflammatory Bowel Disease (IBD)-Associated Colorectal Neoplasia in IBD-Primary Sclerosing Cholangitis (PSC) Appears Greater in Patients Diagnosed With IBD Before PSC
    Dunseth, Craig
    Bellizzi, Andrew
    MODERN PATHOLOGY, 2015, 28 : 158A - 158A
  • [43] Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy
    Khan, Nabeel
    Asim, Hamna
    Lichtenstein, Gary R.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1699 - 1708
  • [44] VEDOLIZUMAB IS NOT ASSOCIATED WITH INCREASED INFECTION RISK IN IMMUNOSUPPRESSED LIVER TRANSPLANT RECIPIENTS WITH INFLAMMATORY BOWEL DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
    Tse, Chung Sang
    Loftus, Edward V.
    Raffals, Laura H.
    Lightner, Amy L.
    GASTROENTEROLOGY, 2019, 156 (06) : S636 - S636
  • [45] UNIQUE PHENOTYPIC CHARACTERISTICS AND USE OF ANTI-TNF THERAPY IN ULCERATIVE COLITIS PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER US EXPERIENCE
    Mousa, Omar Y.
    Wang, Ming-Hsi
    Friton, Jessica
    Raffals, Laura H.
    Leighton, Jonathan A.
    Pasha, Shabana F.
    Picco, Michael F.
    Newberry, Rodney D.
    Faubion, William
    GASTROENTEROLOGY, 2018, 154 (06) : S19 - S20
  • [46] Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement
    Carbone, M.
    Della Penna, A.
    Mazzarelli, C.
    De Martin, E.
    Villard, C.
    Bergquist, A.
    Line, P. D.
    Neuberger, J. M.
    Al-Shakhshir, S.
    Trivedi, P. J.
    Baumann, U.
    Cristoferi, L.
    Hov, J.
    Fischler, B.
    Hadzic, N. H.
    Debray, D.
    D'Antiga, L.
    Selzner, N.
    Belli, L. S.
    Nadalin, S.
    TRANSPLANT INTERNATIONAL, 2023, 36
  • [47] Ileal Pouch-anal Anastomosis in Primary Sclerosing Cholangitis-inflammatory Bowel Disease (PSC-IBD): Long-term Pouch and Liver Transplant Outcomes
    Maspero, Marianna
    Holubar, Stefan D.
    Raj, Roma
    Yilmaz, Sumeyye
    Prien, Christopher
    Lavryk, Olga
    Pita, Alejandro
    Hashimoto, Koji
    Steele, Scott R.
    Hull, Tracy L.
    ANNALS OF SURGERY, 2023, 278 (06) : 961 - 968
  • [48] Risk of Colorectal Cancer With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis Compared to Primary Sclerosing Cholangitis Only: A Need for Consensus on Colonoscopy Surveillance Guidelines for PSC Without IBD
    Das, Taranika Sarkar
    Ho, Kimberly
    Udaikumar, Jahnavi
    Chen, Bryan
    Delau, Olivia
    Shaukat, Aasma
    Jacobson, Ira
    Sarwar, Raiya
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1195 - S1197
  • [49] Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy
    Casanova, Maria Jose
    Chaparro, Maria
    Domenech, Eugeni
    Barreiro-de Acosta, Manuel
    Bermejo, Fernando
    Flores, Eva Iglesias
    Gomollon, Fernando
    Rodrigo, Luis
    Calvet, Xavier
    Esteve, Maria
    Garcia, Esther
    Garcia, S.
    Taxonera, Carlos
    Calvo, Marta
    Lopez, M.
    Ginard, Daniel
    Gomez, Maria
    Garrido, Elena
    Perez-Calle, Jose L.
    Beltran, Belen
    Piqueras, Marta
    Saro, Cristina
    Botella, Belen
    Duenas, Carmen
    Diaz, Angel Ponferrada
    Manosa, Miriam
    Iglesias, Marta
    Algaba, Alicia
    Garcia-Sanchez, Valle
    Mate, J.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2012, 142 (05) : S362 - S363
  • [50] Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy
    Jose Casanova, Maria
    Chaparro, Maria
    Iglesias Flores, Eva
    Rodrigo, Luis
    Domenech, Eugeni
    Calvet, Xavier
    Garcia-Planella, Esther
    Bermejo, Fernando
    Taxonera, Carlos
    Barreiro-de Acosta, Manuel
    Garcia, Acosta S.
    Ginard, Daniel
    Luis Cabriada, Jose
    Garrido, Elena
    Gomez-Garcia, Maria
    Perez-Calle, Jose L.
    Saro, Cristina
    Piqueras, Marta
    Beltran, Belen
    Esteve, Maria
    Botella, Belen
    Duenas, Carmen
    Garcia-Sanchez, Valle
    Mate, J.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S266 - S266